In Ica, Peru: How Medical Ads Got Me Caught in Regulatory Gray Zones
💡 律咖编者按: 本文由律咖网社群读者 CaiXia 投稿分享。 为了方便大家阅读,律咖网编辑 JingJing(微信:lvga2015)对原文进行了细致的逻辑润色与合规性整理。希望能给正在 秘鲁 创业路上的你带来真实的参考。
I never thought I’d be the guy sitting in a dusty office in Ica, Peru, explaining to a local regulator why my electric vehicle ads mentioned “improved circulation” and “reduced fatigue.” I’m not in healthcare. I sell modified EVs for rural transport—convertible battery packs, solar-assisted charging, rugged suspensions for Andean dirt roads. But when I launched a Facebook campaign targeting farmers and clinic workers in Ica, I accidentally crossed into medical advertising territory.
It wasn’t intentional.
I was trying to be practical. “Our vehicles reduce physical strain during long commutes to medical centers,” I wrote. “Ideal for elderly patients and caregivers.” I thought I was just describing utility. In China, that’s standard marketing language. In Peru? Apparently, it triggers a whole different legal framework.
I learned this the hard way.
The Unseen Wall Between Utility and Medical Claims
I first noticed something was off when my ad account got suspended for “potential health-related claims.” I didn’t panic. I reached out to the local digital marketing agency I’d hired—someone recommended by a fellow Chinese trader in Lima. They assured me: “It’s just a glitch. We’ll tweak the wording.”
Two weeks later, I received a notice from DIGEMID (Dirección General de Medicamentos, Insumos y Drogas), Peru’s national drug and medical device regulatory body. The letter was in Spanish, and my translator wasn’t fluent in legal jargon. The key phrase: “actividades publicitarias que puedan inducir a error sobre efectos terapéuticos.” Translation: advertising that may mislead about therapeutic effects.
I had no idea my EV ads were even being monitored under medical advertising law.
This is where the information asymmetry hit me hardest: I thought I was selling a vehicle. The authorities saw potential medical claims. Neither side knew the other’s frame of reference.
I spent three weeks trying to figure out what exactly was prohibited. I called DIGEMID’s public inquiry line. I asked three lawyers in Arequipa. I even emailed a contact at the Ministry of Health—no one gave me a clear answer. Each said: “It depends on context. You need to consult a local attorney who specializes in health communications.”
I realized: there is no public checklist. No official PDF. No website with bullet points. Just scattered guidelines buried in decrees from 2018 and 2021, many not translated into English.
Time cost? I lost 17 days. My ad budget evaporated. My supplier in China asked why I wasn’t shipping. My father in Yunnan, recovering from a stroke, needed better mobility aids. I felt guilty—not just for the business, but because I wasn’t solving his problem fast enough.
My Framework for Navigating the Gray Zone
Here’s how I rebuilt my approach, step by step:
1. Separate product function from health outcome
I stopped saying “reduces fatigue” or “helps seniors.” Instead, I focused on mechanical specs:
“Battery range: 180 km on single charge. Charging time: 4 hours via standard outlet. Weight capacity: 300 kg. Suspension optimized for unpaved roads.”
I added a disclaimer:
“This product is not a medical device. No therapeutic claims are intended or implied.”
2. Use neutral imagery
I replaced photos of elderly patients riding the vehicles with images of farmers hauling sacks, young workers commuting to construction sites, and school buses converted to cargo carriers. No white coats. No stethoscopes. No hospital backgrounds.
3. Audit every word with a local native
I hired a Peruvian freelance copywriter—no agency, just someone from Ica with a degree in communications. She went line by line with me. We flagged even phrases like “easier mobility” as potentially risky. She said: “In Peru, ‘mobility’ in ads often triggers DIGEMID review if paired with age or disability.”
It was exhausting. But it worked.
My ads were re-approved within 10 days.
FAQ: What You Can Actually Do
Q: Can I mention health benefits in ads for non-medical products in Ica, Peru?
A:
- Step: Review DIGEMID’s Resolution No. 048-2018/SUNAT/DGEMID on advertising of products with indirect health implications.
- Path: Access the document via www.digemid.minsa.gob.pe → “Normas Técnicas” → Search “Publicidad.”
- Key points:
• Avoid verbs like “alivia,” “trata,” “mejora,” or “previene” unless you have a registered medical device license.
• Use only objective, measurable features (weight, speed, capacity, energy use).
• Add a disclaimer in Spanish: “Este producto no es un dispositivo médico. No se garantizan efectos terapéuticos.”
Q: Are there specific restrictions in Ica compared to Lima?
A:
- Step: Contact the local health department (Dirección Regional de Salud de Ica).
- Path: Visit their office at Av. San Martín 458, Ica, or email: drsica@minsa.gob.pe.
- Key points:
• Enforcement is often more conservative in provincial areas.
• Rural communities may have higher sensitivity to health-related messaging.
• Local inspectors may not distinguish between “wellness” and “treatment” claims.
Q: How do I check if my product might be classified as a medical device?
A:
- Step: Submit a preliminary classification request to DIGEMID.
- Path: Use the “Sistema de Notificación de Productos” portal at https://snpp.digemid.minsa.gob.pe.
- Key points:
• Even non-invasive products (e.g., massage belts, ergonomic seats) can be classified as medical devices if they claim to affect bodily functions.
• The process takes 30–45 days.
• If classified, you’ll need additional certification—costs start at $2,000 USD.
My Three Actionable Suggestions (Not Promises)
Assume every ad could be reviewed under medical law — even if you’re selling tools, batteries, or furniture. In Peru, the line is thin and rarely marked.
Hire a local copywriter, not just a translator — language is not the issue; cultural interpretation is. A word like “comodidad” (comfort) might be fine in general ads, but dangerous in health-adjacent contexts.
Document everything — keep screenshots of your ad drafts, approval emails, and correspondence. If challenged, you’ll need to prove good faith. I now archive every version on Google Drive with timestamps.
I still think about that moment in Ica, sitting across from the DIGEMID officer who didn’t speak English, and me, holding a printout of my ad with red pen marks. I realized then: I didn’t fail because I was careless. I failed because I assumed the rules were the same everywhere.
I’m not a lawyer. I’m not a marketer. I’m just a guy from Yunnan trying to build something that helps people move better. But if I can make this work in Ica—where the roads are rough, the regulations are quiet, and the people are kind—then maybe others can too.
If you’re running ads in Peru, or thinking about it, I’d love to hear how you’re handling this. I’ve been talking to JingJing from 律咖网 about it lately—she’s helped me see things from a different angle. She’s not selling anything. Just listening. If you want to share your story or just ask a question, her微信号 is lvga2015. No pressure. No promises. Just real talk.
🔗 延伸阅读
🔸 Ludhiana: Canadian Sikh Dies In Peru, Family Worried In Dubai, Factory Owner Ends Life And More.
🗞️ 来源: toi – 📅 2026-03-04
🔗 阅读原文
🔸 At least 41 killed by heavy rains in Peru this year
🗞️ 来源: thestar_my – 📅 2026-03-03
🔗 阅读原文
📌 免责声明
请知悉:律咖网(Lvga.com)是跨境创业公开信息与内容分享平台,不提供法律、税务、会计或合规服务。
本文内容基于公开资料,并由人工编辑与 AI 工具协助整理,仅供信息参考之用,不构成任何法律、投资、移民或商业决策建议。
政策可能随时间变化,请以官方渠道与当地持牌专业人士意见为准。
如内容有需要修订之处,欢迎随时与我联系。
